Company news

Quest Diagnostics Incorporated news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

September 2, 2025

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

August 26, 2025

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

August 25, 2025

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

August 15, 2025

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

August 7, 2025

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

August 5, 2025

Exposure to PFAS in drinking water linked to higher blood levels of these "forever" chemicals

July 30, 2025

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

July 29, 2025

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

July 22, 2025

Quest Diagnostics Introduces Testing for Oropouche Virus

July 15, 2025

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

July 9, 2025

Quest Diagnostics Releases 2024 Corporate Responsibility Report

June 25, 2025

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

June 23, 2025

PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership

June 18, 2025

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

June 10, 2025

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 20, 2025

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 16, 2025

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 13, 2025

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

April 22, 2025

← Newer news releases

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 71 decks. Every deck is listed under its year.